The market took a sharp fall on Friday, after GOOG’s earnings further pressured the selling in techs. In my Market Forecast last weekend, I said, "For the new week, a bulk of earnings will come in… ... Read More
from Wang's Happy Trading
NASDAQ 100's Update, In focus: LRCX, EBAY, CTRP, BIIB, VRTX
October 18, 2012
New York, October 18th (TradersHuddle.com) - The NASDAQ 100 Index is lower trading at 2742.16, which represents -1.21% versus its previous close. The index is mixed for the session with slightly less... Read More
from TradersHuddle.com
Last weekend, in my Market Forecast, I wrote: "For the next week, the market starts in a neutral position with weakness in tech stocks. Financials held up quite well. Earnings season will start with... Read More
from Wang's Happy Trading
(ISIS) Isis Pharmaceuticals Owns 18% of Regulus
October 14, 2012
Isis Pharmaceuticals, Inc. (ISIS) recently announced that it has invested $3 million in biopharma... Visit StockBlogHub to view complete post. Read More
from Stock Blog Hub
Biogen Idec Traders Target Record Highs
October 12, 2012
Call traders took a shine to Biogen Idec Inc. (NASDAQ:BIIB - 147.10) on Thursday, with single-session volume more than tripling the norm...( Read More ) Read More
category
BIIB
(ALKS) Back to Neutral on Alkermes
October 09, 2012
We are moving back to a Neutral recommendation on Alkermes plc (ALKS) as we believe the stock is... Visit StockBlogHub to view complete post. Read More
from Stock Blog Hub
Regulus Therapeutics Inc., founded by Alnylam Pharmaceuticals (ALNY) and Isis Pharmaceuticals, Inc.... Visit StockBlogHub to view complete post. Read More
from Stock Blog Hub
from YCharts
Last weekend, in my Market Forecast, we discussed: "For the new week, it looks like this market needs to work off more steam before the earnings season starts. Again, the pullbacks should be shallow. ... Read More
from Wang's Happy Trading
September 2012 Wrap-Up, What A Month! GMCR, CMG, BIDU, FFIV, CAT, COG, QCOM, WYNN, CF, AGU, V, CRM, NOV, GOOG, ULTA, VRTX, AKAM, BIIB, GOLD, GS, YELP, LNKD
September 29, 2012
September was a really good month for us, as we anticipated a big rally. Central banks around the world coordinated further monetary easing policies to boost up the economies and financial markets. ... Read More
from Wang's Happy Trading
A 52 Week High for Biogen Idec, will it Hold?
September 26, 2012
New York, September 26th (TradersHuddle.com) - Shares of Biogen Idec Inc. ( NASDAQ:BIIB ) booked a new 52 week high today by trading above $156.57, traders are definitely monitoring Biogen's price... Read More
from TradersHuddle.com
Align Technologies and Lilly join the Healthcare model
September 20, 2012
I am very satisfied with the recent performance of the holdings in this Healthcare model. Covestor Ltd. is a registered investment advisor. Covestor licenses investment strategies from its Model... Read More
from Smarter Investing
Biotech Sanofi (NYSE: SNY) Receives Drug Approval
September 14, 2012
from Wealth Daily
Analyst Downgrades: Biogen Idec, Tyco International, and Intel
September 10, 2012
Analysts are weighing in today on biotech firm Biogen Idec Inc. (NASDAQ:BIIB - 152.50), diversified products provider Tyco International Ltd...( Read More ) Read More
category
BIIB
Markets On Super Rally + GOOG Above $700: GOOG, VRTX, BIIB, AKAM, VRTX, GOLD, YELP, GS, LNKD, ULTA
September 07, 2012
If you’ve been following my blog, you’d know that I’ve been talking about a "super rally" for the past 3 weeks. As the market awaited for the ECB, we hung on to our positions on the long side. On... Read More
from Wang's Happy Trading
(ALNY) Alnylam Pharmaceuticals and Monsanto Collaborate
August 30, 2012
Alnylam Pharmaceuticals, Inc. (ALNY) and Monsanto Company (MON) recently formed a strategic... Visit StockBlogHub to view complete post. Read More
from Stock Blog Hub
Alnylam Pharmaceuticals and Isis Pharmaceuticals’ Creation Regulus Therapeutics to Go Public
August 28, 2012
Regulus Therapeutics Inc., founded by Alnylam Pharmaceuticals (ALNY) and Isis Pharmaceuticals, Inc.... Visit StockBlogHub to view complete post. Read More
from Stock Blog Hub
(ISIS) Isis Pharmaceuticals Loss Down on Higher Revenues
August 22, 2012
Isis Pharmaceuticals Inc. (ISIS) reported a net loss of 1 cent per share in the second quarter of... Visit StockBlogHub to view complete post. Read More
from Stock Blog Hub
(ALNY) Alnylam Pharmaceuticals Earns Milestone Payment
August 21, 2012
Alnylam Pharmaceuticals Inc. (ALNY) recently earned development milestone payment of $3.2 million... Visit StockBlogHub to view complete post. Read More
from Stock Blog Hub
(BIIB) Biogen Idec Inks Deal with Regulus
August 20, 2012
Regulus Therapeutics Inc. and Biogen Idec (BIIB) recently entered into a deal to identify microRNAs... Visit StockBlogHub to view complete post. Read More
from Stock Blog Hub
The Covestor health care model is in robust health
August 15, 2012
I added Amgen to the model due to its underlying fundamental and technical strength. Covestor Ltd. is a registered investment advisor. Covestor licenses investment strategies from its Model Managers to... Read More
from Smarter Investing
The pharmaceutical industry is in the midst of one of the biggest patent cliffs with Pfizer’s (PFE)... Visit StockBlogHub to view complete post. Read More
from Stock Blog Hub
(BIIB) Biogen Idec Incorporated – Bull of the Day
August 02, 2012
Biogen Idec’s (BIIB) second quarter EPS of $1.82 was well above the Zacks Consensus Estimate... Visit StockBlogHub to view complete post. Read More
from Stock Blog Hub
Bringing back Healthstream to the model
July 30, 2012
Bringing back Healthstream and buying Intuitive Surgical were among the moves that aided the Healthcare model's June performance. Covestor Ltd. is a registered investment advisor. Covestor licenses... Read More
from Smarter Investing
New Annual Highs: Biogen Idec, Coca-Cola, and Wal-Mart
July 30, 2012
The major market indexes are mixed heading into the final hours of the session...( Read More ) Read More
category
BIIB
Stock Market Facing Headwinds
July 24, 2012
from Wall Street Greek
Biogen Idec Targeted for Bullish Option Play
July 10, 2012
The shares of Biogen Idec Inc. (NASDAQ:BIIB - 143.16) bucked the broad-market trend lower yesterday, likely thanks to a bullish brokerage note...( Read More ) Read More
category
BIIB
Analyst Upgrades: Biogen Idec, Wells Fargo, and Youku
July 09, 2012
Analysts are weighing in today on biotech stock Biogen Idec Inc. (NASDAQ:BIIB - 142.46), banking giant Wells Fargo & Company (NYSE:WFC - 33.05), and Chinese Internet issue Youku Inc...( Read More ) Read More
category
BIIB
Last weekend, in my Market Forecast, I wrote: "First resistance is at 1360, but, this market could run up to test 1380. As discussed last week, financials and energy sectors led the charge. Both... Read More
from Wang's Happy Trading
Market Rallies As Central Banks Promise Action: SPX, Nasdaq, NAV, APA, SLB, EQT, BIIB, CELG, GILD, AAPL, GOOG, AMZN
June 14, 2012
The market has been hovering within a tight range all week: down Monday, up Tuesday, down Wednesday, and now up on Thursday! It was not easy today. Things really weren’t going anywhere and was... Read More
from Wang's Happy Trading
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
